Multiply Labs Raises $20M in Series A Funding
20 Apr, 2021
– Nano Cures Inc., an Austin, Texas-based clinical stage biotechnology and infectious disease immunity platform company, raised $90M pre-IPO funding round.
– The investment will be led by a $20M commitment from Opulence Capital Management, a Dubai based private investment fund, with existing and new investors participating.
– The company intends to use the funds to accelerate the global scale up of its Cures Platform for Covid-19 variants, including vaccines and persistent immunity delivery.